The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
Open accessAbstract
Mesangial and circulating IgA1 with aberrantly glycosylated hinge region O-glycans characterize IgA nephropathy (IgAN). Unlike healthy individuals, some IgA1 is galactose deficient in patients with IgAN, leaving terminal N-acetylgalactosamine residues in the hinge region exposed. Circulating autoantibodies that recognize such galactose-deficient IgA1 as an autoantigen, or the levels of the autoantigen itself, may allow prediction of disease progression. Here, we analyzed serum samples obtained at diagnosis for autoantigen and autoantibodies from 97 patients with IgAN selected from our prospective cohort according to their absolute renal risk for progression to dialysis or death (0, very low; 1, low; 2, high; 3, very high). We also analyzed samples from controls comprising 30 healthy volunteers and 30 patients with non-IgAN disease. The mean follow-up was 13.8 years. We found that mean serum levels of total autoantigen, normalized IgG autoantibody, and total IgA autoantibody were significantly higher in patients than in the combined controls (all P≤0.01). Furthermore, increasing levels correlated with worse clinical outcomes. In Cox regression and Kaplan-Meier analyses, IgG autoantibody levels ≥1.33 predicted dialysis or death (both P≤0.01). In conclusion, these data suggest that serum levels of IgG and IgA autoantibodies strongly associate with the progression of IgAN nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathophysiology of IgA Nephropathy
Suzuki, H., Kiryluk, K., Novak, J., Moldoveanu, Z., Herr, A. B., Renfrow, M. B., Wyatt, R. J., Scolari, F., Mestecky, J., Gharavi, A. G., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050464 · Cited by 910
Self-citation[Intercapillary deposits of IgA-IgG].
Berger, J., & Hinglais, N. (1968) · PubMed · Cited by 800
Tomana, M., Novak, J., Julian, B. A., Matousovic, K., Konecny, K., & Mestecky, J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5535 · Cited by 498
Self-citationSuzuki, H., Fan, R., Zhang, Z., Brown, R., Hall, S., Julian, B. A., Chatham, W. W., Suzuki, Y., Wyatt, R. J., Moldoveanu, Z., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38468 · Cited by 450
Self-citationPatients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Moldoveanu, Z., Wyatt, R. J., Lee, J. Y., Tomana, M., Julian, B. A., Mestecky, J., Huang, W.-Q., Anreddy, S. R., Hall, S., Hastings, M. C., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002185 · Cited by 422
Self-citationMass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy
Hiki, Y., Odani, H., Takahashi, M., Yasuda, Y., Nishimoto, A., Iwase, H., Shinzato, T., Kobayashi, Y., & Maeda, K. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00591.x · Cited by 378
Predicting the Risk for Dialysis or Death in IgA Nephropathy
Berthoux, F., Mohey, H., Laurent, B., Mariat, C., Afiani, A., & Thibaudin, L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040355 · Cited by 361
Self-citationPencina, M. J., D'Agostino, R. B., & Demler, O. V. (2012) · Statistics in Medicine · doi:10.1002/sim.4348 · Cited by 349
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
Tomana, M., Matoušovic, K., Julian, B. A., Radl, J., Konecný, K., & Mestecky, J. (1997) · Kidney International · doi:10.1038/ki.1997.361 · Cited by 341
Self-citationConley, M. E., Cooper, M. D., & Michael, A. F. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109998 · Cited by 331
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients
Allen, A. C., Bailey, E. M., Brenchley, P. E., Buck, K., Barratt, J., & Feehally, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060003969.x · Cited by 311
Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
Gharavi, A. G., Moldoveanu, Z., Wyatt, R. J., Barker, C. V., Woodford, S. Y., Lifton, R. P., Mestecky, J., Novak, J., & Julian, B. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091052 · Cited by 284
Self-citationAlamartine, E., Sabatier, J.-C., Guerin, C., Berliet, J.-M., & Berthoux, F. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80284-8 · Cited by 283
Self-citationGalactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy
ALLEN, A. C., HARPER, S. J., & FEEHALLY, J. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03724.x · Cited by 277
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1
Suzuki, H., Moldoveanu, Z., Hall, S., Brown, R., Vu, H. L., Novak, L., Julian, B. A., Tomana, M., Wyatt, R. J., Edberg, J. C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33189 · Cited by 277
Self-citationKiryluk, K., Moldoveanu, Z., Sanders, J. T., Eison, T. M., Suzuki, H., Julian, B. A., Novak, J., Gharavi, A. G., & Wyatt, R. J. (2011) · Kidney International · doi:10.1038/ki.2011.16 · Cited by 266
Self-citationNovak, J., Tomana, M., Brown, R., Hall, S., Novak, L., Julian, B. A., Wyatt, R. J., Mestecky, J., & Matousovic, K. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67107.x · Cited by 228
Self-citationNatural History of Primary IgA Nephropathy
Berthoux, F. C., Mohey, H., & Afiani, A. (2008) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.10.001 · Cited by 177
Self-citationAn update on the pathogenesis and treatment of IgA nephropathy
Boyd, J. K., Cheung, C. K., Molyneux, K., Feehally, J., & Barratt, J. (2012) · Kidney International · doi:10.1038/ki.2011.501 · Cited by 164
Renfrow, M. B., Cooper, H. J., Tomana, M., Kulhavy, R., Hiki, Y., Toma, K., Emmett, M. R., Mestecky, J. F., Marshall, A. G., & Novák, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411368200 · Cited by 139
Analysis of IgA1 O-Glycans in IgA Nephropathy by Fluorophore-Assisted Carbohydrate Electrophoresis
Allen, A. C., BAILEY, E. M., Barratt, J., Buck, K., & Feehally, J. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1081763 · Cited by 130
Oxidative Stress and Galactose-Deficient IgA1 as Markers of Progression in IgA Nephropathy
Camilla, R., Suzuki, H., Daprà, V., Loiacono, E., Peruzzi, L., Amore, A., Ghiggeri, G. M., Mazzucco, G., Scolari, F., Gharavi, A. G., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11571210 · Cited by 126
Self-citationBellur, S. S., Troyanov, S., Cook, H. T., Roberts, I. S. D., & on behalf of a Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq812 · Cited by 120
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins
Moore, J., Kulhavy, R., Tomana, M., Moldoveanu, Z., Suzuki, H., Brown, R., Hall, S. D., Kilian, M., Poulsen, K., Mestecky, J. F., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.12.011 · Cited by 95
Self-citationGalactose-Deficient IgA1 in African Americans with IgA Nephropathy
Hastings, M. C., Moldoveanu, Z., Julian, B. A., Novák, J., Sanders, J. T., McGlothan, K. R., Gharavi, A. G., & Wyatt, R. J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03270410 · Cited by 81
Self-citationLin, X., Ding, J., Zhu, L., Shi, S., Jiang, L., Zhao, M., & Zhang, H. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp294 · Cited by 75
Gomes, M. M., Suzuki, H., Brooks, M. T., Tomana, M., Moldoveanu, Z., Mestecky, J. F., Julian, B. A., Novák, J., & Herr, A. B. (2010) · Biochemistry · doi:10.1021/bi9019498 · Cited by 44
Self-citationDemler, O., Pencina, M. J., & D’Agostino, R. B. (2011) · Statistics in Medicine · doi:10.1002/sim.4196 · Cited by 36
Cited by
Wyatt, R. J., & Julian, B. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1206793 · Cited by 1,222
Self-citationTrimarchi, H., Barratt, J., Cattran, D. C., Cook, H. T., Coppo, R., Haas, M., Liu, Z.-H., Roberts, I. S. D., Yuzawa, Y., Zhang, H., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.003 · Cited by 1,192
The immune system and kidney disease: basic concepts and clinical implications
Kurts, C., Panzer, U., Anders, H.-J., & Rees, A. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3523 · Cited by 696
Lai, K. N., Tang, S. C. W., Schena, F. P., Novak, J., Tomino, Y., Fogo, A. B., & Glassock, R. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.1 · Cited by 508
Self-citationFloege, J., & Amann, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00272-5 · Cited by 306
Metadata
- Authors
- Berthoux, F., Suzuki, H., Thibaudin, L., Yanagawa, H., Maillard, N., Mariat, C., Tomino, Y., Julian, B. A., & Novak, J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2012-09
- Volume
- 23
- Issue
- 9
- Pages
- 1579-1587
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2125096231
- Cited by
- 272
- References
- 28
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.